Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Doximity Inc. Class A

In a report released yesterday, John Stevenson from Peel Hunt maintained a Buy rating on Dr. Martens Plc. The company’s shares closed yesterday at ...

Peel Hunt Sticks to Their Buy Rating for Dr. Martens Plc (DOCS)

Analysts are intrested in these 5 stocks: ( ($DOCS) ), ( ($WIX) ), ( ($CAKE) ), ( ($SBUX) ) and ( ($VRT) ). Here is a breakdown of their recent


DOCS, WIX, CAKE, SBUX, VRT Trending With Analysts

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Oruka Therapeutics (ORKA), GH Research (GHRS) and Do...

Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA), GH Research (GHRS) and Doximity (DOCS)

In a report released on May 14, Ryan Halsted from RBC Capital maintained a Buy rating on Doximity, with a price target of $28.00. The company’s sha...

RBC Capital Remains a Buy on Doximity (DOCS)

Doximity, Inc. (($DOCS)) has held its Q4 earnings call. Read on for the main highlights of the call. Doximity’s latest earnings call painted a pict...

Doximity Earnings Call: Cash‑Rich, Slower Growth, Big AI Bet

Doximity ($DOCS) shares fell 24% after the company posted mixed Q4 results and issued a weaker outlook for FY2027, which led several analysts to cu...

Current Quarter	$0.23	Next Quarter	$0.28
Current Year	$1.1	Next Year	$1.3
QoQ Growth	+21.7%	YoY Growth	+18.2%
3Y EPS CAGR	+13.2%	Target Price	$25.15
Consensus	Buy	Upside	+28.8%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DOCS	$19.52	-2.11%	3.26M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DOCS	$19.52	-2.1%	3.26M
3
4
5
6

DOCS

DOCS

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Doximity Inc. Class A Data in Excel

Get Doximity Inc. Class A Data in Excel